Total Payments
$4,814
2024 Payments
$1,059
Companies
22
Transactions
364
Medicare Patients
1,135
Medicare Billing
$134,502
Payment Breakdown by Category
Food & Beverage$4,644 (96.5%)
Education$170.23 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,644 | 362 | 96.5% |
| Education | $170.23 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,145 | 71 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,139 | 158 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $685.23 | 38 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $384.71 | 24 | $0 (2024) |
| Alkermes, Inc. | $226.32 | 15 | $0 (2024) |
| Lundbeck LLC | $202.98 | 12 | $0 (2024) |
| Allergan Inc. | $185.78 | 3 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $134.56 | 9 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $131.56 | 8 | $0 (2022) |
| Shire North American Group Inc | $116.87 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,059 | 57 | Janssen Pharmaceuticals, Inc ($292.33) |
| 2023 | $485.32 | 27 | Janssen Pharmaceuticals, Inc ($176.24) |
| 2022 | $852.33 | 65 | Janssen Pharmaceuticals, Inc ($228.15) |
| 2021 | $682.21 | 66 | Teva Pharmaceuticals USA, Inc. ($237.27) |
| 2020 | $117.10 | 8 | Janssen Pharmaceuticals, Inc ($58.53) |
| 2019 | $647.47 | 72 | Teva Pharmaceuticals USA, Inc. ($157.95) |
| 2018 | $757.48 | 55 | Teva Pharmaceuticals USA, Inc. ($386.62) |
| 2017 | $213.06 | 14 | Otsuka America Pharmaceutical, Inc. ($54.53) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/03/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Neurology | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Neuroscience | ||||||
| 09/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 249 | 636 | $92,850 | $31,772 |
| 2022 | 7 | 250 | 602 | $80,850 | $31,930 |
| 2021 | 9 | 349 | 797 | $94,645 | $39,240 |
| 2020 | 7 | 287 | 622 | $79,638 | $31,559 |
Total Patients
1,135
Total Services
2,657
Medicare Billing
$134,502
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 31 | 128 | $33,920 | $13,669 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 126 | $24,105 | $9,286 | 38.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 28 | 43 | $7,525 | $3,052 | 40.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 17 | 17 | $10,275 | $1,874 | 18.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 193 | $4,825 | $1,435 | 29.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 58 | 106 | $10,176 | $1,233 | 12.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 14 | 23 | $2,024 | $1,222 | 60.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 174 | $26,803 | $13,297 | 49.6% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 17 | 70 | $18,550 | $7,937 | 42.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 19 | 58 | $10,150 | $4,400 | 43.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 20 | 20 | $9,399 | $2,633 | 28.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 69 | 109 | $10,224 | $1,330 | 13.0% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 16 | 23 | $2,024 | $1,240 | 61.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 148 | $3,700 | $1,094 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 206 | $32,375 | $16,344 | 50.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 41 | 122 | $21,350 | $9,403 | 44.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 22 | 22 | $12,467 | $3,323 | 26.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 21 | 38 | $3,344 | $2,166 | 64.8% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 13 | 21 | $3,204 | $2,117 | 66.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 36 | 237 | $5,925 | $1,908 | 32.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 71 | 110 | $9,552 | $1,478 | 15.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 14 | $4,126 | $1,353 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 27 | $2,302 | $1,148 | 49.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 47 | 175 | $30,625 | $12,371 | 40.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 135 | $22,863 | $9,592 | 42.0% |
About Dr. Lori Gerding, MD
Dr. Lori Gerding, MD is a Psychiatry healthcare provider based in Moncks Corner, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801834726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Gerding, MD has received a total of $4,814 in payments from pharmaceutical and medical device companies, with $1,059 received in 2024. These payments were reported across 364 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,644).
As a Medicare-enrolled provider, Gerding has provided services to 1,135 Medicare beneficiaries, totaling 2,657 services with total Medicare billing of $134,502. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Moncks Corner, SC
- Active Since 06/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1801834726
Products in Payments
- INVEGA SUSTENNA (Drug) $1,145
- AUSTEDO (Drug) $855.99
- INGREZZA (Drug) $685.23
- REXULTI (Drug) $294.76
- VRAYLAR (Drug) $256.04
- ABILIFY MAINTENA (Drug) $232.12
- LATUDA (Drug) $131.56
- CAPLYTA (Drug) $106.41
- MYDAYIS (Drug) $104.21
- Qelbree (Drug) $103.96
- ARISTADA (Drug) $95.01
- HETLIOZ (Drug) $86.42
- Aristada 441 mg (Drug) $82.16
- UZEDY (Drug) $78.71
- Austedo XR (Drug) $63.98
- LYBALVI (Drug) $49.15
- Fanapt (Drug) $48.14
- TRINTELLIX (Drug) $45.70
- AMPLATZER (Device) $39.13
- PERSERIS (Drug) $33.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Moncks Corner
Dr. Sarah Minter, D.o, D.O
Psychiatry — Payments: $1,499
Psychiatry $1,499
Margaret Rittenbury, Md, MD
Psychiatry — Payments: $812.72
Psychiatry $812.72
Dr. Hillel Glover, Md, MD
Psychiatry — Payments: $42.18
Psychiatry $42.18
Elbert Hodges, Md, MD
Psychiatry
Psychiatry
Dr. Virginia Villeponteaux, M.d, M.D
Psychiatry
Psychiatry